McDonald KL - Search Results

1

Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: A systematic review and meta-analysis.

Lu VM, Jue TR, Phan K, McDonald KL. Lu VM, et al. Among authors: mcdonald kl. Clin Neurol Neurosurg. 2018 Jan;164:75-80. doi: 10.1016/j.clineuro.2017.11.015. Epub 2017 Dec 1. Clin Neurol Neurosurg. 2018. PMID: 29202377

2

Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival.

McDonald KL, McDonnell J, Muntoni A, Henson JD, Hegi ME, von Deimling A, Wheeler HR, Cook RJ, Biggs MT, Little NS, Robinson BG, Reddel RR, Royds JA. McDonald KL, et al. J Neuropathol Exp Neurol. 2010 Jul;69(7):729-36. doi: 10.1097/NEN.0b013e3181e576cf. J Neuropathol Exp Neurol. 2010. PMID: 20535033

3

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.

Tabone T, Abuhusain HJ, Nowak AK; Australian Genomics and Clinical Outcome of Glioma (AGOG) Network; Erber WN, McDonald KL. Tabone T, et al. Among authors: mcdonald kl. J Clin Pathol. 2014 Jul;67(7):550-5. doi: 10.1136/jclinpath-2014-202173. Epub 2014 Apr 2. J Clin Pathol. 2014. PMID: 24695838

4

Incorporation of biomarkers in phase II studies of recurrent glioblastoma.

Jue TR, Hovey E, Davis S, Carleton O, McDonald KL. Jue TR, et al. Among authors: mcdonald kl. Tumour Biol. 2015 Jan;36(1):153-62. doi: 10.1007/s13277-014-2960-3. Epub 2014 Dec 23. Tumour Biol. 2015. PMID: 25534238 Review.

5

Membrane proteome analysis of glioblastoma cell invasion.

Mallawaaratchy DM, Buckland ME, McDonald KL, Li CC, Ly L, Sykes EK, Christopherson RI, Kaufman KL. Mallawaaratchy DM, et al. Among authors: mcdonald kl. J Neuropathol Exp Neurol. 2015 May;74(5):425-41. doi: 10.1097/NEN.0000000000000187. J Neuropathol Exp Neurol. 2015. PMID: 25853691

6

The challenges associated with molecular targeted therapies for glioblastoma.

Jue TR, McDonald KL. Jue TR, et al. Among authors: mcdonald kl. J Neurooncol. 2016 May;127(3):427-34. doi: 10.1007/s11060-016-2080-6. Epub 2016 Feb 22. J Neurooncol. 2016. PMID: 26900075 Review.

7

Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma.

Sinnadurai M, McDonald KL. Sinnadurai M, et al. Among authors: mcdonald kl. J Neurooncol. 2017 May;132(3):359-372. doi: 10.1007/s11060-017-2390-3. Epub 2017 Mar 14. J Neurooncol. 2017. PMID: 28293764 Review.

8

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma.

Jue TR, Nozue K, Lester AJ, Joshi S, Schroder LB, Whittaker SP, Nixdorf S, Rapkins RW, Khasraw M, McDonald KL. Jue TR, et al. Among authors: mcdonald kl. J Transl Med. 2017 Mar 17;15(1):61. doi: 10.1186/s12967-017-1164-1. J Transl Med. 2017. PMID: 28314386 Free PMC article.

9

The current evidence of statin use affecting glioblastoma prognosis.

Lu VM, McDonald KL. Lu VM, et al. Among authors: mcdonald kl. J Clin Neurosci. 2017 Aug;42:196-197. doi: 10.1016/j.jocn.2017.04.036. Epub 2017 May 8. J Clin Neurosci. 2017. PMID: 28495423

10

Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma.

Lu VM, McDonald KL, Townley HE. Lu VM, et al. Among authors: mcdonald kl. Nanomedicine (Lond). 2017 Oct;12(19):2389-2401. doi: 10.2217/nnm-2017-0193. Epub 2017 Sep 4. Nanomedicine (Lond). 2017. PMID: 28868972 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters